Literature DB >> 19367357

Cyclosporine-induced parkinsonism.

Marco A Lima, Simone Maradei, Pericles Maranhao Filho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19367357     DOI： 10.1007/s00415-009-0137-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Parkinsonism during cyclosporine treatment in renal transplantation.

Authors:  Hyun Chul Kim; Seung Yeup Han; Sung Bae Park; Soo Jhi Suh
Journal:  Nephrol Dial Transplant       Date:  2002-02       Impact factor: 5.992

2.  Parkinsonism during cyclosporine treatment.

Authors:  P H Wasserstein; L S Honig
Journal:  Bone Marrow Transplant       Date:  1996-09       Impact factor: 5.483

3.  Movement disorders secondary to long-term treatment with cyclosporine A.

Authors:  Renato P Munhoz; Helio A G Teive; Francisco M B Germiniani; Júlio C Gerytch; Daniel S Sá; Marco A Bittencourt; Ricardo Pasquini; Carlos H F Camargo; Lineu César Werneck
Journal:  Arq Neuropsiquiatr       Date:  2005-09-09       Impact factor: 1.420

4.  Liver transplantation in a patient with rapid onset parkinsonism-dementia complex induced by manganism secondary to liver failure.

Authors:  Giorgio Fabiani; Enio Rogacheski; Júlio César Wiederkehr; Jussara Khouri; Andréa Cianfarano
Journal:  Arq Neuropsiquiatr       Date:  2007-09       Impact factor: 1.420

Review 5.  Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features.

Authors:  B K Kleinschmidt-DeMasters; Brad A Marder; Marilyn E Levi; Stephen P Laird; J Trevor McNutt; Edward J Escott; Gregory T Everson; Kenneth L Tyler
Journal:  Arch Neurol       Date:  2004-08

6.  Acute parkinsonian syndrome with demyelinating leukoencephalopathy in bone marrow transplant recipients.

Authors:  L A Lockman; J H Sung; W Krivit
Journal:  Pediatr Neurol       Date:  1991 Nov-Dec       Impact factor: 3.372

7.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

Review 8.  Extrapyramidal symptoms in a BMT recipient with hyperintense basal ganglia and elevated manganese.

Authors:  S Fredstrom; J Rogosheske; P Gupta; L J Burns
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

9.  Encephalopathy with parkinsonian features in children following bone marrow transplantations and high-dose amphotericin B.

Authors:  S H Mott; R J Packer; L G Vezina; S Kapur; P A Dinndorf; J A Conry; M R Pranzatelli; R R Quinones
Journal:  Ann Neurol       Date:  1995-06       Impact factor: 10.422
  9 in total
  2 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 2.  Movement Disorders and Hematologic Diseases.

Authors:  Roshni Abee Patel; Deborah A Hall; Sheila Eichenseer; Meagan Bailey
Journal:  Mov Disord Clin Pract       Date:  2020-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.